BPC-157 acts primarily on the nitric oxide (NO) system , VEGF-mediated angiogenesis and gastric mucosal protection pathways central to vascular repair, tendon-to-bone healing, and gastrointestinal models
BPC-157, which is derived from human gastric juice, has documented effects on gut mucosal integrity and may support gut health during the disruptive early phase of GLP-1 therapy
These effects typically peak within the first 2 to 4 weeks and diminish significantly as your gastrointestinal tract adjusts to the medication's presence
Pauwels, R
Therefore, issues exist with drug compliance, and the substantial food-drug interactions may potentially generate inconsistent effects in the real-world setting
However, there are certain foods that affect how the medication works and may worsen side effects like nausea, bloating, or stomach discomfort